Scrip Dividend - Total Issued Shares | 04-May-2022 | 15:31 | RNS |
Notice of Forthcoming Scheduled IR Events | 03-May-2022 | 07:00 | RNS |
Scrip Dividend – Calculation Price | 07-Apr-2022 | 15:45 | RNS |
Holding(s) in Company | 01-Apr-2022 | 16:00 | RNS |
Total Voting Rights | 31-Mar-2022 | 15:45 | RNS |
Annual Report and Accounts 2021 and Notice of AGM | 30-Mar-2022 | 12:00 | RNS |
Director/PDMR Shareholding | 25-Mar-2022 | 14:00 | RNS |
Director/PDMR Shareholding | 23-Mar-2022 | 11:30 | RNS |
Director/PDMR Shareholding | 17-Mar-2022 | 14:40 | RNS |
Board Change | 17-Mar-2022 | 14:20 | RNS |
Acquisition Completion of Triad Life Sciences Inc | 14-Mar-2022 | 07:00 | RNS |
Annual Results | 08-Mar-2022 | 07:00 | RNS |
Non-Executive Director Changes | 28-Feb-2022 | 11:00 | RNS |
Holding(s) in Company | 10-Feb-2022 | 15:15 | RNS |
Acquisition: entry into attractive wound biologics | 28-Jan-2022 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 266.20p |
Change Today | 4.00p |
% Change | 1.53 % |
52 Week High | 293.40 |
52 Week Low | 196.20 |
Volume | 4,239,134 |
Shares Issued | 2,049.79m |
Market Cap | £5,456m |
RiskGrade | 96 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 6 |
Buy | 8 |
Neutral | 4 |
Sell | 1 |
Strong Sell | 0 |
Total | 19 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 25-Apr-24 | 17-Aug-23 |
Paid | 23-May-24 | 28-Sep-23 |
Amount | 4.46¢ | 1.77¢ |
Time | Volume / Share Price |
16:51 | 17,496 @ 266.20p |
16:35 | 2,459,511 @ 266.20p |
16:35 | 2 @ 266.20p |
16:35 | 8,802 @ 266.20p |
16:35 | 4,192 @ 266.20p |
CEO | Karim Bitar |
Chair | John McAdam |
CFO | Jonny Mason |
You are here: research